CVS Health Share Holder Equity 2012-2026 | CVS
CVS Health share holder equity from 2012 to 2026. Share holder equity can be defined as the sum of preferred and common equity items
- CVS Health share holder equity for the quarter ending June 30, 2026 was $79.899B, a 3.03% increase year-over-year.
- CVS Health share holder equity for 2025 was $75.382B, a 0.46% decline from 2024.
- CVS Health share holder equity for 2024 was $75.73B, a 1.18% decline from 2023.
- CVS Health share holder equity for 2023 was $76.636B, a 6.78% increase from 2022.
|
CVS Health Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025 | $75,382 |
| 2024 | $75,730 |
| 2023 | $76,636 |
| 2022 | $71,769 |
| 2021 | $75,381 |
| 2020 | $69,701 |
| 2019 | $64,170 |
| 2018 | $58,543 |
| 2017 | $37,695 |
| 2016 | $36,834 |
| 2015 | $37,203 |
| 2014 | $37,963 |
| 2013 | $37,938 |
| 2012 | $37,653 |
| 2011 | $38,051 |
|
CVS Health Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2026-06-30 | $79,899 |
| 2026-03-31 | $77,637 |
| 2025-12-31 | $75,382 |
| 2025-09-30 | $73,110 |
| 2025-06-30 | $77,551 |
| 2025-03-31 | $77,110 |
| 2024-12-31 | $75,730 |
| 2024-09-30 | $75,106 |
| 2024-06-30 | $75,111 |
| 2024-03-31 | $74,150 |
| 2023-12-31 | $76,636 |
| 2023-09-30 | $74,510 |
| 2023-06-30 | $73,002 |
| 2023-03-31 | $71,580 |
| 2022-12-31 | $71,769 |
| 2022-09-30 | $71,011 |
| 2022-06-30 | $75,506 |
| 2022-03-31 | $74,140 |
| 2021-12-31 | $75,381 |
| 2021-09-30 | $74,618 |
| 2021-06-30 | $73,565 |
| 2021-03-31 | $71,164 |
| 2020-12-31 | $69,701 |
| 2020-09-30 | $69,112 |
| 2020-06-30 | $68,355 |
| 2020-03-31 | $65,474 |
| 2019-12-31 | $64,170 |
| 2019-09-30 | $62,933 |
| 2019-06-30 | $61,599 |
| 2019-03-31 | $60,006 |
| 2018-12-31 | $58,543 |
| 2018-09-30 | $36,622 |
| 2018-06-30 | $35,611 |
| 2018-03-31 | $38,677 |
| 2017-12-31 | $37,695 |
| 2017-09-30 | $34,868 |
| 2017-06-30 | $34,147 |
| 2017-03-31 | $33,842 |
| 2016-12-31 | $36,834 |
| 2016-09-30 | $35,954 |
| 2016-06-30 | $34,766 |
| 2016-03-31 | $36,031 |
| 2015-12-31 | $37,203 |
| 2015-09-30 | $37,180 |
| 2015-06-30 | $37,133 |
| 2015-03-31 | $36,995 |
| 2014-12-31 | $37,963 |
| 2014-09-30 | $38,109 |
| 2014-06-30 | $38,132 |
| 2014-03-31 | $38,212 |
| 2013-12-31 | $37,938 |
| 2013-09-30 | $38,534 |
| 2013-06-30 | $38,906 |
| 2013-03-31 | $38,209 |
| 2012-12-31 | $37,653 |
| 2012-09-30 | $36,916 |
| 2012-06-30 | $37,913 |
| 2012-03-31 | $38,053 |
| 2011-12-31 | $38,051 |
| 2011-09-30 | $37,487 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $120.850B | $402.067B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.177B | 25.78 |
| HCA Healthcare (HCA) | United States | $91.758B | 14.27 |
| Elevance Health (ELV) | United States | $90.552B | 14.21 |
| Cencora (COR) | United States | $61.693B | 18.85 |
| Natera (NTRA) | United States | $50.563B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.274B | 18.52 |
| Viatris (VTRS) | United States | $19.124B | 6.61 |
| Medpace Holdings (MEDP) | United States | $17.319B | 36.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.369B | 0.00 |
| DiDi Global (DIDIY) | China | $16.046B | 176.00 |
| Revvity (RVTY) | United States | $15.643B | 26.20 |
| Solventum (SOLV) | United States | $15.330B | 12.69 |
| ICON (ICLR) | Ireland | $13.204B | 17.94 |
| Charles River Laboratories (CRL) | United States | $13.027B | 27.56 |
| BrightSpring Health Services (BTSG) | United States | $11.642B | 40.03 |
| Avantor (AVTR) | United States | $10.443B | 18.83 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.054B | 79.17 |
| HealthEquity (HQY) | United States | $7.983B | 26.01 |
| Sonic Healthcare (SKHHY) | Australia | $6.771B | 0.00 |
| PACS (PACS) | United States | $6.662B | 22.39 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.327B | 0.00 |
| MiniMed (MMED) | United States | $6.193B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.157B | 23.28 |
| Sotera Health (SHC) | United States | $5.416B | 22.33 |
| Concentras Parent (CON) | United States | $4.542B | 22.40 |
| Organon (OGN) | United States | $3.587B | 4.55 |
| GeneDx Holdings (WGS) | United States | $2.822B | 262.89 |
| CareDx (CDNA) | United States | $2.723B | 309.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.169B | 12.71 |
| Alignment Healthcare (ALHC) | United States | $2.151B | 54.58 |
| Establishment Labs Holdings (ESTA) | United States | $2.130B | 0.00 |
| Progyny (PGNY) | United States | $2.130B | 30.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.912B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.907B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.787B | 68.25 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.573B | 0.00 |
| Agilon Health (AGL) | United States | $1.547B | 0.00 |
| Ardent Health (ARDT) | United States | $1.508B | 8.62 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Nutex Health (NUTX) | United States | $1.475B | 8.45 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.204B | 245.88 |
| GoodRx Holdings (GDRX) | United States | $1.196B | 23.27 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| CryoPort (CYRX) | United States | $0.826B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.688B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.472B | 9.77 |
| Strata Critical Medical (SRTA) | United States | $0.468B | 0.00 |
| Forward Industries (FWDI) | United States | $0.449B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.382B | 5.55 |
| Shoulder Innovations (SI) | United States | $0.374B | 0.00 |
| Biodesix (BDSX) | United States | $0.292B | 0.00 |
| Embecta (EMBC) | United States | $0.288B | 2.50 |
| So-Young (SY) | China | $0.276B | 0.00 |
| LifeMD (LFMD) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.098B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.068B | 8.06 |
| Tevogen (TVGN) | United States | $0.050B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.008B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |